HCPCS Level IItemporaryActive
Q2055
Idecabtagene vicleucel car
BETOS: O1D
Effective: 2024-04-04
Referenced in 1 policies
Description
Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
Excluded
This code is excluded from the Medicare Physician Fee Schedule.
Coverage Policies